https://biotechmorning.com/news/varda-251-million-space-drug-manufacturing Biotech Morning en 2026-10-01T14:17:56.377Z The $251 Million Bet on Making Drugs Where There's No Gravity https://biotechmorning.com/news/sanofi-regeneron-billion-dollar-early-stage-deal Biotech Morning en 2026-10-01T14:17:10.806Z Sanofi Just Wrote Regeneron a $1 Billion Check for Drugs That Barely Exist https://biotechmorning.com/news/bms-admilparant-liver-safety-death-fibrosis Biotech Morning en 2026-10-01T14:16:25.694Z The Fibrosis Drug That Killed a Patient Nobody Can Identify https://biotechmorning.com/news/tarlatamab-durvalumab-first-line-sclc-survival Biotech Morning en 2026-10-01T14:15:42.919Z The Cancer Drug Combo That Just Made Immunotherapy History https://biotechmorning.com/news/lilly-amylin-zepbound-combo-record-weight-loss Biotech Morning en 2026-10-01T14:14:53.230Z Lilly's New Weight-Loss Combo Just Smashed Every Record on the Scale https://biotechmorning.com/news/merck-tl1a-hidradenitis-suppurativa-phase-2-win Biotech Morning en 2026-10-01T14:14:05.350Z Merck's $10.8 Billion Bet Just Paid Off in a Place Nobody Expected https://biotechmorning.com/news/viking-obesity-drug-monthly-dosing Biotech Morning en 2026-10-01T14:13:22.423Z The Obesity Shot That Wants You to Forget About It https://biotechmorning.com/news/giredestrant-oral-serd-breast-cancer-evera Biotech Morning en 2026-10-01T14:12:40.350Z The Pill That Could Replace the Needle in Breast Cancer Treatment https://biotechmorning.com/news/fenebrutinib-ms-pill-fda-priority-review Biotech Morning en 2026-10-01T14:11:54.514Z The MS Pill That Wants to Replace Your Infusion https://biotechmorning.com/news/hhs-ai-clinical-trial-overhaul Biotech Morning en 2026-10-01T14:11:08.159Z The Government Wants to Blow Up How Clinical Trials Work https://biotechmorning.com/news/roche-obesity-drug-party Biotech Morning en 2026-09-30T14:18:39.354Z Roche Just Crashed the Obesity Drug Party. Did It Bring Enough to Stay? https://biotechmorning.com/news/uniqure-huntington-gene-therapy-durability-loss Biotech Morning en 2026-09-30T14:17:52.619Z The Gene Therapy That Worked for 3 Years, Then Stopped Working https://biotechmorning.com/news/oral-il-17a-inhibitor-psoriasis-ascletis Biotech Morning en 2026-09-30T14:16:59.112Z The Pill That Wants to Replace Your Psoriasis Injection https://biotechmorning.com/news/roche-autonomous-ai-labs Biotech Morning en 2026-09-30T14:16:12.453Z Roche Wants to Fire Its Lab Scientists (and Replace Them With Robots) https://biotechmorning.com/news/peanut-patch-seven-years-fda-door Biotech Morning en 2026-09-30T14:15:29.583Z The Peanut Patch That Took Seven Years to Reach the FDA's Door https://biotechmorning.com/news/phrma-eric-cantor-ceo-former-congressman Biotech Morning en 2026-09-30T14:14:42.872Z Big Pharma's New Weapon Against Washington Is a Former Congressman https://biotechmorning.com/news/amgen-lupus-graveyard-phase-2-win Biotech Morning en 2026-09-30T14:13:58.871Z Amgen Just Survived Biotech's Most Notorious Graveyard https://biotechmorning.com/news/beam-therapeutics-trade-secret-lawsuit-yoltech-serapha Biotech Morning en 2026-09-30T14:13:13.693Z Beam Therapeutics Says a Scientist Walked Out With Its Secret Recipe https://biotechmorning.com/news/obesity-drug-petrelintide-lower-dose-twist Biotech Morning en 2026-09-30T14:12:32.127Z The Obesity Drug That Worked Better at a Lower Dose https://biotechmorning.com/news/lilly-retatrutide-phase-3-obesity-data Biotech Morning en 2026-09-30T14:11:43.321Z Eli Lilly's New Weight-Loss Drug Just Made the Competition Look Small